January 9, 2013 By Steven E. Greer, MD (Courtesy The Healthcare Channel) After the JPMorgan healthcare conference, I realized how much has changed. I’m so old, that I can remember when: Rituxan used to be the focus of investors for BIIB Companies had topline growth No one cared about Europe, much less “emerging markets” Stents [...]
↧